Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyman

Showing results (51-60 of 2,155) with videos related to

Pageof 216
Sort By:
The Neurohospitalist|April 26, 2024
A Molecular Framework for DeliriumKyle A Lyman
Advances in Experimental Medicine and Biology|January 1, 1993
Perinatal AIDS: drugs of abuse and transplacental infectionW D Lyman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Normal tissue complication probabilities: variable dose per fractionJ T Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Impact of chemotherapy dose intensity on cancer patient outcomesGary H Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|July 26, 2005
Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidenceGary H Lyman
Oncology (Williston Park, N.Y.)|March 21, 2007
Chemotherapy dose intensity and quality cancer careGary H Lyman
Journal of Psychoactive Drugs|January 23, 2016
Cannabis: The Issue is ControlDonald O Lyman
Emergency Medicine Clinics of North America|May 1, 1986
Blood urea nitrogen and creatinineJ L Lyman
Current Opinion in Hematology|July 17, 1998
Biologic effects and potential clinical applications of Flt3 ligandS D Lyman
Journal of the National Cancer Institute|March 17, 1993
Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapyG H Lyman, C G Lyman, R A Sanderson, et al.
Pageof 216

Showing results (51-60 of 2,155) with videos related to

Sort By:
Pageof 216
The Neurohospitalist|April 26, 2024
A Molecular Framework for DeliriumKyle A Lyman
Advances in Experimental Medicine and Biology|January 1, 1993
Perinatal AIDS: drugs of abuse and transplacental infectionW D Lyman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Normal tissue complication probabilities: variable dose per fractionJ T Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Impact of chemotherapy dose intensity on cancer patient outcomesGary H Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|July 26, 2005
Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidenceGary H Lyman
Oncology (Williston Park, N.Y.)|March 21, 2007
Chemotherapy dose intensity and quality cancer careGary H Lyman
Journal of Psychoactive Drugs|January 23, 2016
Cannabis: The Issue is ControlDonald O Lyman
Emergency Medicine Clinics of North America|May 1, 1986
Blood urea nitrogen and creatinineJ L Lyman
Current Opinion in Hematology|July 17, 1998
Biologic effects and potential clinical applications of Flt3 ligandS D Lyman
Journal of the National Cancer Institute|March 17, 1993
Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapyG H Lyman, C G Lyman, R A Sanderson, et al.
Pageof 216